nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—thyroid cancer	0.706	1	CbGaD
Desmopressin—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00748	0.0607	CbGpPWpGaD
Desmopressin—PTGS2—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.00594	0.0481	CbGpPWpGaD
Desmopressin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00563	0.0456	CbGpPWpGaD
Desmopressin—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00447	0.0362	CbGpPWpGaD
Desmopressin—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—PRKAR1A—thyroid cancer	0.00383	0.031	CbGpPWpGaD
Desmopressin—AVPR1B—Peptide GPCRs—TSHR—thyroid cancer	0.00366	0.0297	CbGpPWpGaD
Desmopressin—AVPR2—Arf6 trafficking events—TSHR—thyroid cancer	0.00362	0.0294	CbGpPWpGaD
Desmopressin—AVPR2—G alpha (s) signalling events—CALCB—thyroid cancer	0.0036	0.0292	CbGpPWpGaD
Desmopressin—AVPR2—Aquaporin-mediated transport—PRKAR1A—thyroid cancer	0.00334	0.0271	CbGpPWpGaD
Desmopressin—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00306	0.0248	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00266	0.0216	CbGpPWpGaD
Desmopressin—AVPR1A—Peptide GPCRs—TSHR—thyroid cancer	0.00254	0.0206	CbGpPWpGaD
Desmopressin—AVPR2—Peptide GPCRs—TSHR—thyroid cancer	0.00252	0.0204	CbGpPWpGaD
Desmopressin—PTGS2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00243	0.0197	CbGpPWpGaD
Desmopressin—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00203	0.0165	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—CALCB—thyroid cancer	0.0019	0.0154	CbGpPWpGaD
Desmopressin—AVPR2—G alpha (s) signalling events—TSHR—thyroid cancer	0.00167	0.0135	CbGpPWpGaD
Desmopressin—PTGS2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00161	0.0131	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00158	0.0128	CbGpPWpGaD
Desmopressin—AVPR1B—Peptide ligand-binding receptors—SST—thyroid cancer	0.00134	0.0109	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—CALCB—thyroid cancer	0.00132	0.0107	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CALCB—thyroid cancer	0.00131	0.0106	CbGpPWpGaD
Desmopressin—AVPR2—G alpha (s) signalling events—CALCA—thyroid cancer	0.00125	0.0101	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00115	0.00936	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—CALCB—thyroid cancer	0.00107	0.0087	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.00106	0.00856	CbGpPWpGaD
Desmopressin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.00101	0.00818	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CALCB—thyroid cancer	0.000975	0.0079	CbGpPWpGaD
Desmopressin—AVPR1A—Peptide ligand-binding receptors—SST—thyroid cancer	0.000928	0.00752	CbGpPWpGaD
Desmopressin—AVPR2—Peptide ligand-binding receptors—SST—thyroid cancer	0.000921	0.00747	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000898	0.00728	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—TSHR—thyroid cancer	0.000879	0.00713	CbGpPWpGaD
Desmopressin—Cardiac disorder—Sorafenib—thyroid cancer	0.00082	0.00481	CcSEcCtD
Desmopressin—Flushing—Sorafenib—thyroid cancer	0.00082	0.00481	CcSEcCtD
Desmopressin—Dyspepsia—Vandetanib—thyroid cancer	0.000819	0.00481	CcSEcCtD
Desmopressin—Dermatitis atopic—Doxorubicin—thyroid cancer	0.000813	0.00477	CcSEcCtD
Desmopressin—Decreased appetite—Vandetanib—thyroid cancer	0.000809	0.00475	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000803	0.00472	CcSEcCtD
Desmopressin—Fatigue—Vandetanib—thyroid cancer	0.000802	0.00471	CcSEcCtD
Desmopressin—Angiopathy—Sorafenib—thyroid cancer	0.000801	0.00471	CcSEcCtD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.0008	0.00649	CbGpPWpGaD
Desmopressin—Immune system disorder—Sorafenib—thyroid cancer	0.000798	0.00469	CcSEcCtD
Desmopressin—Mediastinal disorder—Sorafenib—thyroid cancer	0.000796	0.00467	CcSEcCtD
Desmopressin—Pain—Vandetanib—thyroid cancer	0.000795	0.00467	CcSEcCtD
Desmopressin—Constipation—Vandetanib—thyroid cancer	0.000795	0.00467	CcSEcCtD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000795	0.00644	CbGpPWpGaD
Desmopressin—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.000791	0.00641	CbGpPWpGaD
Desmopressin—Mental disorder—Sorafenib—thyroid cancer	0.000774	0.00454	CcSEcCtD
Desmopressin—Malnutrition—Sorafenib—thyroid cancer	0.000769	0.00452	CcSEcCtD
Desmopressin—Erythema—Sorafenib—thyroid cancer	0.000769	0.00452	CcSEcCtD
Desmopressin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000761	0.00447	CcSEcCtD
Desmopressin—AVPR1B—GPCR ligand binding—PTCH1—thyroid cancer	0.000748	0.00606	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—CALCB—thyroid cancer	0.000744	0.00603	CbGpPWpGaD
Desmopressin—Vasodilation—Epirubicin—thyroid cancer	0.00074	0.00434	CcSEcCtD
Desmopressin—Vasodilation procedure—Epirubicin—thyroid cancer	0.00074	0.00434	CcSEcCtD
Desmopressin—Muscle spasms—Sorafenib—thyroid cancer	0.000739	0.00434	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—CALCB—thyroid cancer	0.000739	0.00599	CbGpPWpGaD
Desmopressin—Body temperature increased—Vandetanib—thyroid cancer	0.000735	0.00432	CcSEcCtD
Desmopressin—Abdominal pain—Vandetanib—thyroid cancer	0.000735	0.00432	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.000733	0.00594	CbGpPWpGaD
Desmopressin—Thinking abnormal—Epirubicin—thyroid cancer	0.00071	0.00417	CcSEcCtD
Desmopressin—Oliguria—Epirubicin—thyroid cancer	0.000705	0.00414	CcSEcCtD
Desmopressin—Syncope—Sorafenib—thyroid cancer	0.000689	0.00405	CcSEcCtD
Desmopressin—Vasodilation procedure—Doxorubicin—thyroid cancer	0.000684	0.00402	CcSEcCtD
Desmopressin—Vasodilation—Doxorubicin—thyroid cancer	0.000684	0.00402	CcSEcCtD
Desmopressin—AVPR1B—GPCR ligand binding—SST—thyroid cancer	0.000684	0.00554	CbGpPWpGaD
Desmopressin—Loss of consciousness—Sorafenib—thyroid cancer	0.000676	0.00397	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—CALCB—thyroid cancer	0.000676	0.00548	CbGpPWpGaD
Desmopressin—Cough—Sorafenib—thyroid cancer	0.000671	0.00394	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—CALCB—thyroid cancer	0.000671	0.00544	CbGpPWpGaD
Desmopressin—Asthenia—Vandetanib—thyroid cancer	0.000667	0.00392	CcSEcCtD
Desmopressin—Hypertension—Sorafenib—thyroid cancer	0.000664	0.0039	CcSEcCtD
Desmopressin—AVPR1B—GPCR ligand binding—CALCA—thyroid cancer	0.000658	0.00534	CbGpPWpGaD
Desmopressin—Pruritus—Vandetanib—thyroid cancer	0.000658	0.00386	CcSEcCtD
Desmopressin—Thinking abnormal—Doxorubicin—thyroid cancer	0.000657	0.00386	CcSEcCtD
Desmopressin—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.000656	0.00531	CbGpPWpGaD
Desmopressin—Myalgia—Sorafenib—thyroid cancer	0.000655	0.00384	CcSEcCtD
Desmopressin—Oliguria—Doxorubicin—thyroid cancer	0.000653	0.00383	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00065	0.00382	CcSEcCtD
Desmopressin—Diarrhoea—Vandetanib—thyroid cancer	0.000636	0.00374	CcSEcCtD
Desmopressin—Influenza like illness—Epirubicin—thyroid cancer	0.000631	0.00371	CcSEcCtD
Desmopressin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000627	0.00369	CcSEcCtD
Desmopressin—Infection—Sorafenib—thyroid cancer	0.000623	0.00366	CcSEcCtD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000623	0.00504	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000618	0.00501	CbGpPWpGaD
Desmopressin—Shock—Sorafenib—thyroid cancer	0.000617	0.00363	CcSEcCtD
Desmopressin—Fluid retention—Epirubicin—thyroid cancer	0.000617	0.00362	CcSEcCtD
Desmopressin—Nervous system disorder—Sorafenib—thyroid cancer	0.000615	0.00361	CcSEcCtD
Desmopressin—Dizziness—Vandetanib—thyroid cancer	0.000615	0.00361	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—TSHR—thyroid cancer	0.00061	0.00494	CbGpPWpGaD
Desmopressin—Skin disorder—Sorafenib—thyroid cancer	0.000609	0.00358	CcSEcCtD
Desmopressin—AVPR2—GPCR ligand binding—TSHR—thyroid cancer	0.000605	0.0049	CbGpPWpGaD
Desmopressin—Anorexia—Sorafenib—thyroid cancer	0.000598	0.00351	CcSEcCtD
Desmopressin—Coma—Epirubicin—thyroid cancer	0.000594	0.00349	CcSEcCtD
Desmopressin—Vomiting—Vandetanib—thyroid cancer	0.000591	0.00347	CcSEcCtD
Desmopressin—Rash—Vandetanib—thyroid cancer	0.000586	0.00344	CcSEcCtD
Desmopressin—Dermatitis—Vandetanib—thyroid cancer	0.000586	0.00344	CcSEcCtD
Desmopressin—Influenza like illness—Doxorubicin—thyroid cancer	0.000584	0.00343	CcSEcCtD
Desmopressin—Headache—Vandetanib—thyroid cancer	0.000583	0.00342	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—CALCB—thyroid cancer	0.000576	0.00467	CbGpPWpGaD
Desmopressin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000572	0.00336	CcSEcCtD
Desmopressin—Fluid retention—Doxorubicin—thyroid cancer	0.000571	0.00335	CcSEcCtD
Desmopressin—Mental disability—Epirubicin—thyroid cancer	0.000564	0.00331	CcSEcCtD
Desmopressin—Dyspnoea—Sorafenib—thyroid cancer	0.000559	0.00329	CcSEcCtD
Desmopressin—Nausea—Vandetanib—thyroid cancer	0.000553	0.00324	CcSEcCtD
Desmopressin—Dyspepsia—Sorafenib—thyroid cancer	0.000552	0.00324	CcSEcCtD
Desmopressin—Coma—Doxorubicin—thyroid cancer	0.00055	0.00323	CcSEcCtD
Desmopressin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000549	0.00445	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TRIM33—thyroid cancer	0.000546	0.00442	CbGpPWpGaD
Desmopressin—Decreased appetite—Sorafenib—thyroid cancer	0.000545	0.0032	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000542	0.00318	CcSEcCtD
Desmopressin—Fatigue—Sorafenib—thyroid cancer	0.000541	0.00318	CcSEcCtD
Desmopressin—Constipation—Sorafenib—thyroid cancer	0.000537	0.00315	CcSEcCtD
Desmopressin—Pain—Sorafenib—thyroid cancer	0.000537	0.00315	CcSEcCtD
Desmopressin—Mental disability—Doxorubicin—thyroid cancer	0.000522	0.00307	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—PTCH1—thyroid cancer	0.000518	0.0042	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—PTCH1—thyroid cancer	0.000515	0.00417	CbGpPWpGaD
Desmopressin—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000514	0.00417	CbGpPWpGaD
Desmopressin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000513	0.00301	CcSEcCtD
Desmopressin—Increased appetite—Epirubicin—thyroid cancer	0.000502	0.00295	CcSEcCtD
Desmopressin—Urticaria—Sorafenib—thyroid cancer	0.000498	0.00293	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—TSHR—thyroid cancer	0.000497	0.00403	CbGpPWpGaD
Desmopressin—Body temperature increased—Sorafenib—thyroid cancer	0.000496	0.00291	CcSEcCtD
Desmopressin—Abdominal pain—Sorafenib—thyroid cancer	0.000496	0.00291	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—SST—thyroid cancer	0.000474	0.00384	CbGpPWpGaD
Desmopressin—Hyponatraemia—Epirubicin—thyroid cancer	0.000474	0.00278	CcSEcCtD
Desmopressin—AVPR2—GPCR ligand binding—SST—thyroid cancer	0.000471	0.00381	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000468	0.0038	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000468	0.0038	CbGpPWpGaD
Desmopressin—Increased appetite—Doxorubicin—thyroid cancer	0.000465	0.00273	CcSEcCtD
Desmopressin—Affect lability—Epirubicin—thyroid cancer	0.000464	0.00273	CcSEcCtD
Desmopressin—Hypersensitivity—Sorafenib—thyroid cancer	0.000462	0.00272	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000462	0.00375	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000461	0.00374	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—CALCA—thyroid cancer	0.000456	0.0037	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CALCA—thyroid cancer	0.000453	0.00367	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—TSHR—thyroid cancer	0.000451	0.00366	CbGpPWpGaD
Desmopressin—Asthenia—Sorafenib—thyroid cancer	0.00045	0.00264	CcSEcCtD
Desmopressin—Mood swings—Epirubicin—thyroid cancer	0.000447	0.00262	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000444	0.0036	CbGpPWpGaD
Desmopressin—Pruritus—Sorafenib—thyroid cancer	0.000444	0.00261	CcSEcCtD
Desmopressin—Dehydration—Epirubicin—thyroid cancer	0.000439	0.00258	CcSEcCtD
Desmopressin—Hyponatraemia—Doxorubicin—thyroid cancer	0.000438	0.00257	CcSEcCtD
Desmopressin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000431	0.00253	CcSEcCtD
Desmopressin—Affect lability—Doxorubicin—thyroid cancer	0.00043	0.00252	CcSEcCtD
Desmopressin—Hypokalaemia—Epirubicin—thyroid cancer	0.000429	0.00252	CcSEcCtD
Desmopressin—Diarrhoea—Sorafenib—thyroid cancer	0.000429	0.00252	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000425	0.0025	CcSEcCtD
Desmopressin—Dizziness—Sorafenib—thyroid cancer	0.000415	0.00244	CcSEcCtD
Desmopressin—Mood swings—Doxorubicin—thyroid cancer	0.000414	0.00243	CcSEcCtD
Desmopressin—Abdominal distension—Epirubicin—thyroid cancer	0.000411	0.00241	CcSEcCtD
Desmopressin—Influenza—Epirubicin—thyroid cancer	0.000408	0.00239	CcSEcCtD
Desmopressin—Dehydration—Doxorubicin—thyroid cancer	0.000406	0.00238	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—CALCB—thyroid cancer	0.000399	0.00323	CbGpPWpGaD
Desmopressin—Vomiting—Sorafenib—thyroid cancer	0.000399	0.00234	CcSEcCtD
Desmopressin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000399	0.00234	CcSEcCtD
Desmopressin—Hypokalaemia—Doxorubicin—thyroid cancer	0.000397	0.00233	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—CALCB—thyroid cancer	0.000396	0.00321	CbGpPWpGaD
Desmopressin—Rash—Sorafenib—thyroid cancer	0.000396	0.00232	CcSEcCtD
Desmopressin—Dermatitis—Sorafenib—thyroid cancer	0.000395	0.00232	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000393	0.00231	CcSEcCtD
Desmopressin—Headache—Sorafenib—thyroid cancer	0.000393	0.00231	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—SST—thyroid cancer	0.000386	0.00313	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—PTCH1—thyroid cancer	0.000384	0.00311	CbGpPWpGaD
Desmopressin—Abdominal distension—Doxorubicin—thyroid cancer	0.00038	0.00223	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000379	0.00307	CbGpPWpGaD
Desmopressin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000379	0.00223	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—TRIM33—thyroid cancer	0.000378	0.00307	CbGpPWpGaD
Desmopressin—Influenza—Doxorubicin—thyroid cancer	0.000377	0.00222	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—TRIM33—thyroid cancer	0.000376	0.00304	CbGpPWpGaD
Desmopressin—Nausea—Sorafenib—thyroid cancer	0.000373	0.00219	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—CALCA—thyroid cancer	0.000372	0.00302	CbGpPWpGaD
Desmopressin—Weight increased—Epirubicin—thyroid cancer	0.000371	0.00218	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000368	0.00298	CbGpPWpGaD
Desmopressin—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000365	0.00295	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TCF7L1—thyroid cancer	0.000364	0.00295	CbGpPWpGaD
Desmopressin—Conjunctivitis—Epirubicin—thyroid cancer	0.000353	0.00208	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—SST—thyroid cancer	0.000351	0.00284	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000351	0.00284	CbGpPWpGaD
Desmopressin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000351	0.00206	CcSEcCtD
Desmopressin—Sweating—Epirubicin—thyroid cancer	0.000349	0.00205	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—TSHR—thyroid cancer	0.000344	0.00279	CbGpPWpGaD
Desmopressin—Weight increased—Doxorubicin—thyroid cancer	0.000343	0.00202	CcSEcCtD
Desmopressin—Epistaxis—Epirubicin—thyroid cancer	0.000343	0.00201	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—TSHR—thyroid cancer	0.000342	0.00277	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CALCA—thyroid cancer	0.000338	0.00274	CbGpPWpGaD
Desmopressin—Rhinitis—Epirubicin—thyroid cancer	0.000327	0.00192	CcSEcCtD
Desmopressin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000327	0.00192	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000326	0.00264	CbGpPWpGaD
Desmopressin—Sweating—Doxorubicin—thyroid cancer	0.000323	0.00189	CcSEcCtD
Desmopressin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000322	0.00189	CcSEcCtD
Desmopressin—Oedema peripheral—Epirubicin—thyroid cancer	0.000322	0.00189	CcSEcCtD
Desmopressin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000321	0.00188	CcSEcCtD
Desmopressin—Urethral disorder—Epirubicin—thyroid cancer	0.00032	0.00188	CcSEcCtD
Desmopressin—Epistaxis—Doxorubicin—thyroid cancer	0.000317	0.00186	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000316	0.00256	CbGpPWpGaD
Desmopressin—Visual impairment—Epirubicin—thyroid cancer	0.000315	0.00185	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—TSHR—thyroid cancer	0.000313	0.00254	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—TSHR—thyroid cancer	0.000311	0.00252	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000308	0.00249	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CDK1—thyroid cancer	0.000306	0.00248	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000306	0.00248	CbGpPWpGaD
Desmopressin—Eye disorder—Epirubicin—thyroid cancer	0.000305	0.00179	CcSEcCtD
Desmopressin—Flushing—Epirubicin—thyroid cancer	0.000303	0.00178	CcSEcCtD
Desmopressin—Cardiac disorder—Epirubicin—thyroid cancer	0.000303	0.00178	CcSEcCtD
Desmopressin—Rhinitis—Doxorubicin—thyroid cancer	0.000303	0.00178	CcSEcCtD
Desmopressin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000298	0.00175	CcSEcCtD
Desmopressin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000298	0.00175	CcSEcCtD
Desmopressin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000297	0.00174	CcSEcCtD
Desmopressin—Angiopathy—Epirubicin—thyroid cancer	0.000296	0.00174	CcSEcCtD
Desmopressin—Urethral disorder—Doxorubicin—thyroid cancer	0.000296	0.00174	CcSEcCtD
Desmopressin—Immune system disorder—Epirubicin—thyroid cancer	0.000295	0.00173	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000295	0.00239	CbGpPWpGaD
Desmopressin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000294	0.00173	CcSEcCtD
Desmopressin—Chills—Epirubicin—thyroid cancer	0.000293	0.00172	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—thyroid cancer	0.000291	0.00171	CcSEcCtD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00029	0.00235	CbGpPWpGaD
Desmopressin—Mental disorder—Epirubicin—thyroid cancer	0.000286	0.00168	CcSEcCtD
Desmopressin—Malnutrition—Epirubicin—thyroid cancer	0.000284	0.00167	CcSEcCtD
Desmopressin—Erythema—Epirubicin—thyroid cancer	0.000284	0.00167	CcSEcCtD
Desmopressin—Eye disorder—Doxorubicin—thyroid cancer	0.000282	0.00166	CcSEcCtD
Desmopressin—Cardiac disorder—Doxorubicin—thyroid cancer	0.00028	0.00165	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—thyroid cancer	0.00028	0.00165	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—thyroid cancer	0.00028	0.00164	CcSEcCtD
Desmopressin—Tension—Epirubicin—thyroid cancer	0.000279	0.00164	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000277	0.00225	CbGpPWpGaD
Desmopressin—Nervousness—Epirubicin—thyroid cancer	0.000276	0.00162	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—thyroid cancer	0.000274	0.00161	CcSEcCtD
Desmopressin—Muscle spasms—Epirubicin—thyroid cancer	0.000273	0.0016	CcSEcCtD
Desmopressin—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000273	0.00221	CbGpPWpGaD
Desmopressin—Immune system disorder—Doxorubicin—thyroid cancer	0.000273	0.0016	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000272	0.0016	CcSEcCtD
Desmopressin—Chills—Doxorubicin—thyroid cancer	0.000271	0.00159	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—SST—thyroid cancer	0.000268	0.00217	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TSHR—thyroid cancer	0.000267	0.00216	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PTCH1—thyroid cancer	0.000266	0.00216	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—SST—thyroid cancer	0.000266	0.00216	CbGpPWpGaD
Desmopressin—Mental disorder—Doxorubicin—thyroid cancer	0.000265	0.00155	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—PTCH1—thyroid cancer	0.000264	0.00214	CbGpPWpGaD
Desmopressin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000264	0.00155	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—thyroid cancer	0.000263	0.00154	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—thyroid cancer	0.000263	0.00154	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000263	0.00213	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PRKAR1A—thyroid cancer	0.000262	0.00213	CbGpPWpGaD
Desmopressin—Agitation—Epirubicin—thyroid cancer	0.000261	0.00153	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—thyroid cancer	0.000259	0.00152	CcSEcCtD
Desmopressin—Tension—Doxorubicin—thyroid cancer	0.000258	0.00152	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—CALCA—thyroid cancer	0.000258	0.00209	CbGpPWpGaD
Desmopressin—Malaise—Epirubicin—thyroid cancer	0.000256	0.0015	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—CALCA—thyroid cancer	0.000256	0.00207	CbGpPWpGaD
Desmopressin—Nervousness—Doxorubicin—thyroid cancer	0.000255	0.0015	CcSEcCtD
Desmopressin—Vertigo—Epirubicin—thyroid cancer	0.000255	0.0015	CcSEcCtD
Desmopressin—Syncope—Epirubicin—thyroid cancer	0.000255	0.0015	CcSEcCtD
Desmopressin—Muscle spasms—Doxorubicin—thyroid cancer	0.000253	0.00148	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—TCF7L1—thyroid cancer	0.000252	0.00205	CbGpPWpGaD
Desmopressin—Palpitations—Epirubicin—thyroid cancer	0.000251	0.00147	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—TCF7L1—thyroid cancer	0.000251	0.00203	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MEN1—thyroid cancer	0.000251	0.00203	CbGpPWpGaD
Desmopressin—Loss of consciousness—Epirubicin—thyroid cancer	0.00025	0.00147	CcSEcCtD
Desmopressin—Cough—Epirubicin—thyroid cancer	0.000248	0.00146	CcSEcCtD
Desmopressin—Convulsion—Epirubicin—thyroid cancer	0.000246	0.00145	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—thyroid cancer	0.000245	0.00144	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000244	0.00143	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—SST—thyroid cancer	0.000243	0.00197	CbGpPWpGaD
Desmopressin—Myalgia—Epirubicin—thyroid cancer	0.000242	0.00142	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—thyroid cancer	0.000242	0.00142	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—thyroid cancer	0.000242	0.00142	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—SST—thyroid cancer	0.000242	0.00196	CbGpPWpGaD
Desmopressin—Anxiety—Epirubicin—thyroid cancer	0.000241	0.00142	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000241	0.00195	CbGpPWpGaD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00024	0.00141	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—thyroid cancer	0.000239	0.0014	CcSEcCtD
Desmopressin—Malaise—Doxorubicin—thyroid cancer	0.000237	0.00139	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—thyroid cancer	0.000236	0.00139	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—thyroid cancer	0.000236	0.00138	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—CALCA—thyroid cancer	0.000234	0.0019	CbGpPWpGaD
Desmopressin—Confusional state—Epirubicin—thyroid cancer	0.000234	0.00137	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—CALCA—thyroid cancer	0.000232	0.00188	CbGpPWpGaD
Desmopressin—Palpitations—Doxorubicin—thyroid cancer	0.000232	0.00136	CcSEcCtD
Desmopressin—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000232	0.00188	CbGpPWpGaD
Desmopressin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000232	0.00136	CcSEcCtD
Desmopressin—Oedema—Epirubicin—thyroid cancer	0.000232	0.00136	CcSEcCtD
Desmopressin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000231	0.00136	CcSEcCtD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000231	0.00187	CbGpPWpGaD
Desmopressin—Infection—Epirubicin—thyroid cancer	0.00023	0.00135	CcSEcCtD
Desmopressin—Cough—Doxorubicin—thyroid cancer	0.000229	0.00135	CcSEcCtD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000229	0.00186	CbGpPWpGaD
Desmopressin—Shock—Epirubicin—thyroid cancer	0.000228	0.00134	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—thyroid cancer	0.000228	0.00134	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—thyroid cancer	0.000227	0.00134	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—thyroid cancer	0.000227	0.00133	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—PTCH1—thyroid cancer	0.000227	0.00184	CbGpPWpGaD
Desmopressin—Tachycardia—Epirubicin—thyroid cancer	0.000226	0.00133	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000226	0.00183	CbGpPWpGaD
Desmopressin—Skin disorder—Epirubicin—thyroid cancer	0.000225	0.00132	CcSEcCtD
Desmopressin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000224	0.00132	CcSEcCtD
Desmopressin—Chest pain—Doxorubicin—thyroid cancer	0.000224	0.00131	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—thyroid cancer	0.000224	0.00131	CcSEcCtD
Desmopressin—Anxiety—Doxorubicin—thyroid cancer	0.000223	0.00131	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000222	0.00131	CcSEcCtD
Desmopressin—Discomfort—Doxorubicin—thyroid cancer	0.000221	0.0013	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—thyroid cancer	0.000221	0.0013	CcSEcCtD
Desmopressin—Confusional state—Doxorubicin—thyroid cancer	0.000216	0.00127	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000215	0.00126	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—thyroid cancer	0.000215	0.00126	CcSEcCtD
Desmopressin—Infection—Doxorubicin—thyroid cancer	0.000213	0.00125	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—CDK1—thyroid cancer	0.000212	0.00172	CbGpPWpGaD
Desmopressin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000211	0.00124	CcSEcCtD
Desmopressin—Shock—Doxorubicin—thyroid cancer	0.000211	0.00124	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—CDK1—thyroid cancer	0.00021	0.00171	CbGpPWpGaD
Desmopressin—Nervous system disorder—Doxorubicin—thyroid cancer	0.00021	0.00124	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—thyroid cancer	0.00021	0.00123	CcSEcCtD
Desmopressin—Tachycardia—Doxorubicin—thyroid cancer	0.000209	0.00123	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—thyroid cancer	0.000208	0.00122	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—thyroid cancer	0.000208	0.00122	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000207	0.00122	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—SST—thyroid cancer	0.000207	0.00168	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000207	0.00168	CbGpPWpGaD
Desmopressin—Dyspnoea—Epirubicin—thyroid cancer	0.000207	0.00121	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—thyroid cancer	0.000206	0.00121	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—thyroid cancer	0.000205	0.0012	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—thyroid cancer	0.000204	0.0012	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—thyroid cancer	0.000202	0.00118	CcSEcCtD
Desmopressin—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000201	0.00163	CbGpPWpGaD
Desmopressin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.0002	0.00118	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—thyroid cancer	0.0002	0.00117	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—CALCA—thyroid cancer	0.0002	0.00162	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000199	0.00162	CbGpPWpGaD
Desmopressin—Pain—Epirubicin—thyroid cancer	0.000198	0.00116	CcSEcCtD
Desmopressin—Constipation—Epirubicin—thyroid cancer	0.000198	0.00116	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000195	0.00115	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—thyroid cancer	0.000194	0.00114	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—thyroid cancer	0.000193	0.00113	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000192	0.00156	CbGpPWpGaD
Desmopressin—Dyspnoea—Doxorubicin—thyroid cancer	0.000191	0.00112	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—thyroid cancer	0.000191	0.00112	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—thyroid cancer	0.000191	0.00112	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00019	0.00111	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—thyroid cancer	0.000189	0.00111	CcSEcCtD
Desmopressin—Decreased appetite—Doxorubicin—thyroid cancer	0.000187	0.0011	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000185	0.00109	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—thyroid cancer	0.000185	0.00109	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—TSHR—thyroid cancer	0.000185	0.0015	CbGpPWpGaD
Desmopressin—Urticaria—Epirubicin—thyroid cancer	0.000184	0.00108	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—thyroid cancer	0.000183	0.00108	CcSEcCtD
Desmopressin—Pain—Doxorubicin—thyroid cancer	0.000183	0.00108	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—TSHR—thyroid cancer	0.000183	0.00149	CbGpPWpGaD
Desmopressin—Body temperature increased—Epirubicin—thyroid cancer	0.000183	0.00108	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—thyroid cancer	0.000183	0.00108	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000182	0.00147	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CDK1—thyroid cancer	0.000181	0.00146	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PRKAR1A—thyroid cancer	0.00018	0.00146	CbGpPWpGaD
Desmopressin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000177	0.00104	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000176	0.00143	CbGpPWpGaD
Desmopressin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000175	0.00103	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—MEN1—thyroid cancer	0.000174	0.00141	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.000173	0.0014	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MEN1—thyroid cancer	0.000172	0.0014	CbGpPWpGaD
Desmopressin—Hypersensitivity—Epirubicin—thyroid cancer	0.000171	0.001	CcSEcCtD
Desmopressin—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000171	0.00138	CbGpPWpGaD
Desmopressin—Urticaria—Doxorubicin—thyroid cancer	0.00017	0.001	CcSEcCtD
Desmopressin—Body temperature increased—Doxorubicin—thyroid cancer	0.00017	0.000996	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—thyroid cancer	0.00017	0.000996	CcSEcCtD
Desmopressin—Asthenia—Epirubicin—thyroid cancer	0.000166	0.000977	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—thyroid cancer	0.000164	0.000964	CcSEcCtD
Desmopressin—PTGS2—Disease—TRIM24—thyroid cancer	0.000162	0.00131	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CHST14—thyroid cancer	0.00016	0.0013	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MINPP1—thyroid cancer	0.000159	0.00129	CbGpPWpGaD
Desmopressin—Diarrhoea—Epirubicin—thyroid cancer	0.000159	0.000932	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000158	0.000928	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—PTCH1—thyroid cancer	0.000157	0.00127	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTCH1—thyroid cancer	0.000156	0.00126	CbGpPWpGaD
Desmopressin—Asthenia—Doxorubicin—thyroid cancer	0.000154	0.000904	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—thyroid cancer	0.000153	0.000901	CcSEcCtD
Desmopressin—PTGS2—Disease—CHST14—thyroid cancer	0.000152	0.00123	CbGpPWpGaD
Desmopressin—Pruritus—Doxorubicin—thyroid cancer	0.000152	0.000892	CcSEcCtD
Desmopressin—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	0.000149	0.0012	CbGpPWpGaD
Desmopressin—Vomiting—Epirubicin—thyroid cancer	0.000147	0.000866	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—thyroid cancer	0.000147	0.000862	CcSEcCtD
Desmopressin—Rash—Epirubicin—thyroid cancer	0.000146	0.000859	CcSEcCtD
Desmopressin—Dermatitis—Epirubicin—thyroid cancer	0.000146	0.000858	CcSEcCtD
Desmopressin—Headache—Epirubicin—thyroid cancer	0.000145	0.000853	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—NRG1—thyroid cancer	0.000145	0.00118	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TRIM33—thyroid cancer	0.000144	0.00117	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SST—thyroid cancer	0.000144	0.00116	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SST—thyroid cancer	0.000143	0.00116	CbGpPWpGaD
Desmopressin—Dizziness—Doxorubicin—thyroid cancer	0.000142	0.000833	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—CALCA—thyroid cancer	0.000138	0.00112	CbGpPWpGaD
Desmopressin—Nausea—Epirubicin—thyroid cancer	0.000138	0.000809	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—CALCA—thyroid cancer	0.000137	0.00111	CbGpPWpGaD
Desmopressin—Vomiting—Doxorubicin—thyroid cancer	0.000136	0.000801	CcSEcCtD
Desmopressin—PTGS2—Metabolism—NDUFA13—thyroid cancer	0.000135	0.0011	CbGpPWpGaD
Desmopressin—Rash—Doxorubicin—thyroid cancer	0.000135	0.000795	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—thyroid cancer	0.000135	0.000794	CcSEcCtD
Desmopressin—Headache—Doxorubicin—thyroid cancer	0.000134	0.000789	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	0.000132	0.00107	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TERT—thyroid cancer	0.00013	0.00106	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—HPGD—thyroid cancer	0.000129	0.00105	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	0.000128	0.00104	CbGpPWpGaD
Desmopressin—Nausea—Doxorubicin—thyroid cancer	0.000127	0.000749	CcSEcCtD
Desmopressin—PTGS2—Metabolism—CHST14—thyroid cancer	0.000127	0.00103	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDK1—thyroid cancer	0.000125	0.00101	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HIF1A—thyroid cancer	0.000125	0.00101	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDK1—thyroid cancer	0.000124	0.00101	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—NRAS—thyroid cancer	0.00011	0.000889	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	0.000109	0.000881	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000105	0.00085	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—BRAF—thyroid cancer	0.000103	0.000836	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HPGD—thyroid cancer	0.000103	0.000832	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NRG1—thyroid cancer	0.000101	0.000815	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NRG1—thyroid cancer	9.98e-05	0.000809	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TCF7L1—thyroid cancer	9.62e-05	0.00078	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—KRAS—thyroid cancer	9.44e-05	0.000765	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TERT—thyroid cancer	9.02e-05	0.000731	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TERT—thyroid cancer	8.96e-05	0.000726	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.95e-05	0.000725	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	8.67e-05	0.000702	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.64e-05	0.0007	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HIF1A—thyroid cancer	8.63e-05	0.000699	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HIF1A—thyroid cancer	8.57e-05	0.000694	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.33e-05	0.000675	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—HRAS—thyroid cancer	8.03e-05	0.00065	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—AKT1—thyroid cancer	7.8e-05	0.000632	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—NRAS—thyroid cancer	7.6e-05	0.000616	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—NRAS—thyroid cancer	7.55e-05	0.000612	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CCND1—thyroid cancer	7.53e-05	0.00061	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TPR—thyroid cancer	7.43e-05	0.000602	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PRKAR1A—thyroid cancer	7.31e-05	0.000592	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PTEN—thyroid cancer	7.26e-05	0.000589	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—BRAF—thyroid cancer	7.15e-05	0.000579	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—BRAF—thyroid cancer	7.1e-05	0.000575	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—AKT1—thyroid cancer	7.09e-05	0.000574	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TPR—thyroid cancer	7.04e-05	0.000571	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRKAR1A—thyroid cancer	6.93e-05	0.000561	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.63e-05	0.000538	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.62e-05	0.000537	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MEN1—thyroid cancer	6.62e-05	0.000536	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—KRAS—thyroid cancer	6.54e-05	0.00053	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—KRAS—thyroid cancer	6.5e-05	0.000527	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NRAS—thyroid cancer	6.48e-05	0.000525	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TPR—thyroid cancer	5.9e-05	0.000478	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.9e-05	0.000478	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PRKAR1A—thyroid cancer	5.8e-05	0.00047	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KRAS—thyroid cancer	5.58e-05	0.000452	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HRAS—thyroid cancer	5.56e-05	0.000451	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC5A5—thyroid cancer	5.56e-05	0.000451	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HRAS—thyroid cancer	5.52e-05	0.000448	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—AKT1—thyroid cancer	5.41e-05	0.000438	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—AKT1—thyroid cancer	5.37e-05	0.000435	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CALCA—thyroid cancer	5.27e-05	0.000427	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.26e-05	0.000426	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CCND1—thyroid cancer	5.22e-05	0.000423	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.21e-05	0.000422	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCND1—thyroid cancer	5.18e-05	0.00042	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTEN—thyroid cancer	5.03e-05	0.000408	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTEN—thyroid cancer	5e-05	0.000405	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.98e-05	0.000403	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—thyroid cancer	4.96e-05	0.000402	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—AKT1—thyroid cancer	4.91e-05	0.000398	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—AKT1—thyroid cancer	4.88e-05	0.000395	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDK1—thyroid cancer	4.77e-05	0.000387	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HRAS—thyroid cancer	4.74e-05	0.000384	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—RXRA—thyroid cancer	4.67e-05	0.000379	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.54e-05	0.000368	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NRAS—thyroid cancer	4.49e-05	0.000364	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NRAS—thyroid cancer	4.46e-05	0.000361	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC5A5—thyroid cancer	4.41e-05	0.000358	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKT1—thyroid cancer	4.19e-05	0.000339	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KRAS—thyroid cancer	3.87e-05	0.000313	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KRAS—thyroid cancer	3.84e-05	0.000311	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NRG1—thyroid cancer	3.83e-05	0.00031	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—RXRA—thyroid cancer	3.71e-05	0.000301	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.61e-05	0.000292	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TERT—thyroid cancer	3.44e-05	0.000279	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—thyroid cancer	3.44e-05	0.000278	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—thyroid cancer	3.41e-05	0.000276	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HIF1A—thyroid cancer	3.29e-05	0.000266	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HRAS—thyroid cancer	3.29e-05	0.000266	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HRAS—thyroid cancer	3.26e-05	0.000264	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PPARG—thyroid cancer	2.95e-05	0.000239	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKT1—thyroid cancer	2.9e-05	0.000235	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKT1—thyroid cancer	2.88e-05	0.000233	CbGpPWpGaD
Desmopressin—PTGS2—Disease—BRAF—thyroid cancer	2.72e-05	0.000221	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PPARG—thyroid cancer	2.34e-05	0.00019	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTGS2—thyroid cancer	2.32e-05	0.000188	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTEN—thyroid cancer	2.02e-05	0.000164	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTEN—thyroid cancer	1.92e-05	0.000155	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NRAS—thyroid cancer	1.71e-05	0.000139	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTEN—thyroid cancer	1.61e-05	0.00013	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KRAS—thyroid cancer	1.47e-05	0.000119	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HRAS—thyroid cancer	1.25e-05	0.000101	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKT1—thyroid cancer	1.17e-05	9.45e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKT1—thyroid cancer	1.11e-05	8.96e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKT1—thyroid cancer	9.26e-06	7.5e-05	CbGpPWpGaD
